176 related articles for article (PubMed ID: 17234125)
1. Vaccination against prion diseases.
Kalinke U; Bach P; König M; Buchholz CJ
Discov Med; 2006 Feb; 6(31):29-34. PubMed ID: 17234125
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
3. Cells and prions: a license to replicate.
Nuvolone M; Aguzzi A; Heikenwalder M
FEBS Lett; 2009 Aug; 583(16):2674-84. PubMed ID: 19527722
[TBL] [Abstract][Full Text] [Related]
4. Prion diseases: from molecular biology to intervention strategies.
Nunziante M; Gilch S; Schätzl HM
Chembiochem; 2003 Dec; 4(12):1268-84. PubMed ID: 14661267
[TBL] [Abstract][Full Text] [Related]
5. Generating antibodies against the native form of the human prion protein (hPrP) in wild-type animals: a comparison between DNA and protein immunizations.
Alexandrenne C; Wijkhuisen A; Dkhissi F; Hanoux V; Créminon C; Boquet D; Couraud JY
J Immunol Methods; 2009 Feb; 341(1-2):41-9. PubMed ID: 19027745
[TBL] [Abstract][Full Text] [Related]
6. Immunisation strategies against prion diseases: prime-boost immunisation with a PrP DNA vaccine containing foreign helper T-cell epitopes does not prevent mouse scrapie.
Nitschke C; Flechsig E; van den Brandt J; Lindner N; Lührs T; Dittmer U; Klein MA
Vet Microbiol; 2007 Aug; 123(4):367-76. PubMed ID: 17499458
[TBL] [Abstract][Full Text] [Related]
7. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
Gilch S; Nunziante M; Ertmer A; Schätzl HM
Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
[TBL] [Abstract][Full Text] [Related]
8. Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies.
Buchholz CJ; Bach P; Nikles D; Kalinke U
Expert Opin Biol Ther; 2006 Mar; 6(3):293-300. PubMed ID: 16503737
[TBL] [Abstract][Full Text] [Related]
9. Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion.
Ishibashi D; Yamanaka H; Yamaguchi N; Yoshikawa D; Nakamura R; Okimura N; Yamaguchi Y; Shigematsu K; Katamine S; Sakaguchi S
Vaccine; 2007 Jan; 25(6):985-92. PubMed ID: 17055125
[TBL] [Abstract][Full Text] [Related]
10. Electrotransfer of cDNA coding for a heterologous prion protein generates autoantibodies against native murine prion protein in wild-type mice.
Alexandrenne C; Wijkhuisen A; Dkhissi F; Hanoux V; Priam F; Allard B; Boquet D; Couraud JY
DNA Cell Biol; 2010 Mar; 29(3):121-31. PubMed ID: 20025536
[TBL] [Abstract][Full Text] [Related]
11. Generation of antibodies against bovine recombinant prion protein in various strains of mice.
Andrievskaia O; McRae H; Elmgren C; Huang H; Balachandran A; Nielsen K
Clin Vaccine Immunol; 2006 Jan; 13(1):98-105. PubMed ID: 16426006
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in mucosal vaccines against prion diseases.
Sakaguchi S; Arakawa T
Expert Rev Vaccines; 2007 Feb; 6(1):75-85. PubMed ID: 17280480
[TBL] [Abstract][Full Text] [Related]
13. Species-specificity of a panel of prion protein antibodies for the immunohistochemical study of animal and human prion diseases.
Furuoka H; Yabuzoe A; Horiuchi M; Tagawa Y; Yokoyama T; Yamakawa Y; Shinagawa M; Sata T
J Comp Pathol; 2007 Jan; 136(1):9-17. PubMed ID: 17270205
[TBL] [Abstract][Full Text] [Related]
14. Vaccine approaches to prevent and treat prion infection : progress and challenges.
Müller-Schiffmann A; Korth C
BioDrugs; 2008; 22(1):45-52. PubMed ID: 18215090
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases.
Tayebi M; Hawke S
Immunol Lett; 2006 Jun; 105(2):123-6. PubMed ID: 16621033
[TBL] [Abstract][Full Text] [Related]
16. Is vaccination against transmissible spongiform encephalopathy feasible?
Wisniewski T; Chabalgoity JA; Goni F
Rev Sci Tech; 2007 Apr; 26(1):243-51. PubMed ID: 17633306
[TBL] [Abstract][Full Text] [Related]
17. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
18. Mammalian prion proteins: enigma, variation and vaccination.
Westaway D; Carlson GA
Trends Biochem Sci; 2002 Jun; 27(6):301-7. PubMed ID: 12069790
[TBL] [Abstract][Full Text] [Related]
19. Polyclonal anti-idiotypic antibodies which mimic an epitope of the human prion protein.
Hanoux V; Wijkhuisen A; Alexandrenne C; Créminon C; Boquet D; Couraud JY
Mol Immunol; 2009 Mar; 46(6):1076-83. PubMed ID: 19012967
[TBL] [Abstract][Full Text] [Related]
20. Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies.
Bade S; Frey A
Expert Rev Vaccines; 2007 Apr; 6(2):153-68. PubMed ID: 17408366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
